Can I read Epigenetics-based Therapeutics for Myocardial Fibrosis on EtoBox?

Epigenetics-based Therapeutics for Myocardial Fibrosis by Xuping Li; Ying Yang; Sixuan Chen; Jiuyao Zhou; Jingyan Li; Yuanyuan Cheng is a Neuroscience article available to read on EtoBox.

What is Epigenetics-based Therapeutics for Myocardial Fibrosis about?

Myocardial fibrosis (MF) is a reactive remodeling process in response to myocardial injury. It is mainly manifested by the proliferation of cardiac muscle fibroblasts and secreting extracellular matrix (ECM) proteins to replace damaged tissue. However, the excessive production and deposition of extracellular matrix, and the rising proportion of type I and type III collagen lead to pathological fibrotic remodeling, thereby facilitating the development of cardiac dysfunction and eventually causing heart failure with heightened mortality. Currently, the molecular mechanisms of MF are still not fully understood. With the development of epigenetics, it is found that epigenetics controls the transcription of pro-fibrotic genes in MF by DNA methylation, histone modification and noncoding RNAs. In this review, we summarize and discuss the research progress of the mechanisms underlying MF from the perspective of epigenetics, including the newest m6A modification and crosstalk between different epigenetics in MF. We also offer a succinct overview of promising molecules targeting epigenetic regulators, which may provide novel therapeutic strategies against MF.

Who reads Epigenetics-based Therapeutics for Myocardial Fibrosis?

Author

Xuping Li; Ying Yang; Sixuan Chen; Jiuyao Zhou; Jingyan Li; Yuanyuan Cheng

Publisher

Elsevier BV

Published

2021

Language

EN

Field

Neuroscience (Life Sciences)